America Movil on Pace for Largest Percent Decrease Since August 2022 — Data Talk
America Movil SAB de CV Sponsored ADR Class B (AMX) is currently at $16.34, down $0.80 or 4.67%
--Would be lowest close since Oct. 14, 2022, when it closed at $16.15
--On pace for largest percent decrease since Aug. 2, 2022, when it fell 5.16%
--Snaps a two day winning streak
--Down 5.66% month-to-date
--Down 10.22% year-to-date
--Down 51.8% from its all-time closing high of $33.90 on Oct. 18, 2007
--Down 2.74% from 52 weeks ago (Oct. 19, 2022), when it closed at $16.80
--Down 28.83% from its 52-week closing high of $22.96 on May 16, 2023
--Would be a new 52-week closing low
--Traded as low as $16.00; lowest intraday level since July 28, 2021, when it hit $15.99
--Down 6.68% at today's intraday low; largest intraday percent decrease since May 31, 2022, when it fell as much as 7.27%
All data as of 3:17:39 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 18, 2023 15:36 ET (19:36 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track